Bioética en tiempos de pandemia: Ensayos clínicos con cloroquina para el tratamiento de COVID-19

Authors

DOI:

https://doi.org/10.15448/1984-6746.2020.2.37991

Keywords:

Bioethics. COVID-19. Pandemic. Research ethics. New drugs. Public health policies.

Abstract

We defend the need to act with ethical rigor during the pandemic of the novel coronavirus and not to loosen scientific and normative standards in research on possible drugs, especially chloroquine, for COVID-19. We argue that, exceptionally, it would be justified to skip some steps in conducting clinical trials or experimental treatments, but that it is inappropriate to make indiscriminate use of off-label drugs to treat patients until the results of the research are published in vehicles of proven scientific reputation. To support this position, we apply bioethical principles and medical ethics. We argue that public policies for
the use of Chloroquine during the pandemic should not be implemented until the results of the research carried out by the «COVID Brasil Coalition” and by WHO (World Health Organization) Solidarity are released.

Downloads

Download data is not yet available.

Author Biographies

Alcino Eduardo Bonella, Universidade Federal de Uberlândia (UFU), Uberlândia, MS.

Professor na Universidade Federal de Uberlândia (UFU) em Uberlândia, MS, Brasil. Pesquisador do CNPq.

Marcelo de Araujo, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ.

Doutor em Filosofia pela Universidade de Konstanz (Alemanha). Professor Associado de Ética da Universidade do Estado do Rio de Janeiro (UERJ) no Rio de Janeiro, RJ, Brasil e professor Associado IV de Filosofia do Direito da Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil. Pesquisador do CNPq.

Darlei Dall’Agnoll, Universidade Federal de Santa Catarina (UFSC), Florianópolis, SC.

Doutor em Filosofia na University of Bristol. Professor titular da Universidade Federal de Santa Catarina (UFSC) em Florianópolis, SC, Brasil, Pesquisador do CNPq.

References

AZEVEDO, Marco. The Precautionary Principle. In: DOMINGUES, I. Biotechnologies and the Human Condition.

Belo Horizonte: Editora UFMG, 2012.

BEAUCHAMP, T.; CHILDRESS, J. Principles of Biomedical Ethics. 7. ed. Oxford: Oxford University Press, 2016.

DALL’AGNOL. Bioética. 2. ed. Rio de Janeiro: Zahar, 2015.

DOMINGUES, I. Biotechnologies and the Human Condition. Belo Horizonte: Editora UFMG, 2012.

Downloads

Published

2020-07-27

How to Cite

Bonella, A. E., Araujo, M. de, & Dall’Agnoll, D. (2020). Bioética en tiempos de pandemia: Ensayos clínicos con cloroquina para el tratamiento de COVID-19. Veritas (Porto Alegre), 65(2), e37991. https://doi.org/10.15448/1984-6746.2020.2.37991

Issue

Vol. 65 No. 2 (2020)

Section

Varia

License

Copyright (c) 2020 Veritas (Porto Alegre)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright

The submission of originals to Revista Veritas implies the transfer by the authors of the right for publication. Authors retain copyright and grant the journal right of first publication. If the authors wish to include the same data into another publication, they must cite Revista Veritas as the site of original publication.


Creative Commons License

Except where otherwise specified, material published in this journal is licensed under a Creative Commons Attribution 4.0 International license, which allows unrestricted use, distribution and reproduction in any medium, provided the original publication is correctly cited. Copyright: © 2006-2020 EDIPUCRS</p